Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Beckers

Showing results (121-130 of 175) with videos related to

Pageof 18
Sort By:
Frontiers in Endocrinology|March 14, 2024
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantismManuela Caruso, Diego Mazzatenta, Sofia Asioli, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 19, 2018
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ CellsMichela Anna Polidoro, Sandra Rotondi, Roberta Morace, et al.
The Journal of Endocrinology|September 23, 2016
A vital region for human glycoprotein hormone trafficking revealed by an LHB mutationIulia Potorac, Adolfo Rivero-Müller, Ashutosh Trehan, et al.
Endocrine Connections|March 10, 2019
AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patientsAdrian F Daly, Liliya Rostomyan, Daniela Betea, et al.
International Journal of Cancer|July 29, 2009
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegalyMarily Theodoropoulou, Maria A Tichomirowa, Caroline Sievers, et al.
European Journal of Endocrinology|May 14, 2011
Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasisElena Livadariu, Renata S Auriemma, Catherine Rydlewski, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomasAnne Barlier, Jean-François Vanbellinghen, Adrian F Daly, et al.
The New England Journal of Medicine|January 28, 2026
A 12,000-Year-Old Case of <i>NPR2</i>-Related Acromesomelic DysplasiaDaniel M Fernandes, Alejandro Llanos-Lizcano, Florian Brück, et al.
Journal of Clinical Pharmacology|May 8, 2014
Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: a randomized, multicenter, open-label, phase I studyStephan Petersenn, Jens Bollerslev, Ayman M Arafat, et al.
Molecular and Cellular Endocrinology|February 14, 2016
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cellsSandra Rotondi, Alessio Modarelli, Maria-Antonietta Oliva, et al.
Pageof 18

Showing results (121-130 of 175) with videos related to

Sort By:
Pageof 18
Frontiers in Endocrinology|March 14, 2024
Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantismManuela Caruso, Diego Mazzatenta, Sofia Asioli, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|July 19, 2018
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ CellsMichela Anna Polidoro, Sandra Rotondi, Roberta Morace, et al.
The Journal of Endocrinology|September 23, 2016
A vital region for human glycoprotein hormone trafficking revealed by an LHB mutationIulia Potorac, Adolfo Rivero-Müller, Ashutosh Trehan, et al.
Endocrine Connections|March 10, 2019
AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patientsAdrian F Daly, Liliya Rostomyan, Daniela Betea, et al.
International Journal of Cancer|July 29, 2009
Tumor ZAC1 expression is associated with the response to somatostatin analog therapy in patients with acromegalyMarily Theodoropoulou, Maria A Tichomirowa, Caroline Sievers, et al.
European Journal of Endocrinology|May 14, 2011
Mutations of calcium-sensing receptor gene: two novel mutations and overview of impact on calcium homeostasisElena Livadariu, Renata S Auriemma, Catherine Rydlewski, et al.
The Journal of Clinical Endocrinology and Metabolism|February 15, 2007
Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomasAnne Barlier, Jean-François Vanbellinghen, Adrian F Daly, et al.
The New England Journal of Medicine|January 28, 2026
A 12,000-Year-Old Case of <i>NPR2</i>-Related Acromesomelic DysplasiaDaniel M Fernandes, Alejandro Llanos-Lizcano, Florian Brück, et al.
Journal of Clinical Pharmacology|May 8, 2014
Pharmacokinetics, pharmacodynamics, and safety of pasireotide LAR in patients with acromegaly: a randomized, multicenter, open-label, phase I studyStephan Petersenn, Jens Bollerslev, Ayman M Arafat, et al.
Molecular and Cellular Endocrinology|February 14, 2016
Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cellsSandra Rotondi, Alessio Modarelli, Maria-Antonietta Oliva, et al.
Pageof 18